Abstract:Introduction Heart failure (HF) and atrial fibrillation (AF) frequently co‐exist. Contemporary classification of HF categorizes it into HF with reduced ejection fraction (HFrEF), HF with mildly reduced ejection fraction (HFmrEF), and HF with preserved ejection fraction (HFpEF). Aggregate data comparing the risk profile of AF between these three HF categories are lacking. Methods We conducted a systematic review and meta‐analysis aimed at determining any significant differences in AF‐associated all‐cause mortality, HF hospitalizations, cardiovascular mortality (CV), and stroke between HFrEF, HFmrEF, and HFpEF. A systematic search of PubMed, EMBASE, and Cochrane Library databases until February 28, 2023. Data were combined using DerSimonian‐Laird random effects model. Results A total of 22 studies comprising 248 323 patients were retained: HFrEF 123 331 (49.7%), HFmrEF 40 995 (16.5%), and HFpEF 83 997 (33.8%). Pooled baseline AF prevalence was 36% total population, 30% HFrEF, 36% HFmrEF, and 42% HFpEF. AF was associated with a higher risk of all‐cause mortality in the total population with pooled hazard ratio (HR) = 1.13 (95% confidence interval [CI] = 1.07−1.21), HFmrEF (HR = 1.25, 95% CI = 1.05−1.50) and HFpEF (HR = 1.16, 95% CI = 1.09−1.24), but not HFrEF (HR = 1.03, 95% CI = 0.93−1.14). AF was associated with a higher risk of HF hospitalizations in the total population (HR = 1.29, 95% CI = 1.14−1.46), HFmrEF (HR = 1.64, 95% CI = 1.20−2.24), and HFpEF (HR = 1.46, 95% CI = 1.17−1.83), but not HFrEF (HR = 1.01, 95% CI = 0.87−1.18). AF was only associated with CV in the HFpEF subcategory but was associated with stroke in all three HF subtypes. Conclusions AF appears to be associated with a higher risk of all‐cause mortality and HF hospitalization in HFmrEF and HFpEF. With these findings, the paucity of data and treatment guidelines on AF in the HFmrEF subgroup becomes even more significant and warrant further investigations.

Risk factors modification in atrial fibrillation: a brief review

Stroke risk stratification in atrial fibrillation: a review of common risk factors

Risk Factor Management in Atrial Fibrillation.

Atrial fibrillation: A review of modifiable risk factors and preventive strategies

Epidemiology and modifiable risk factors for atrial fibrillation

Atrial fibrillation risk factors in patients with ischemic stroke

Update on Atrial Fibrillation: Part I

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Atrial fibrillation: comorbidities, lifestyle, and patient factors

Epidemiology and significance of atrial fibrillation

A COMPREHENSIVE NARRATIVE REVIEW OF ATRIAL FIBRILLATION: CURRENT INSIGHTS AND FUTURE DIRECTIONS

Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification

A Comprehensive Narrative Review of Current Understanding and Recent Updates

Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients

Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta‐analysis

Current Strategies for Atrial Fibrillation Prevention and Management: Taming the Commonest Cardiac Arrhythmia

Advances in risk assessment of new-onset atrial fibrillation

Association Between Cardiovascular Risk Factors and Atrial Fibrillation

Investigating the link between coronary artery calcification and atrial fibrillation: A systematic review and meta-analysis

Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.